Authors


Timothy Wilens, MD

Latest:

Substance Use Among Adolescents and Young Adults

In this CME, check out best practices for screening and treating adolescents and young adults with substance use issues.


Tina Beychok

Latest:

News Brief: ICU Staff May Suffer From Psychiatric Difficulties

Caregivers in high-pressure medical settings, such as intenstive care units (ICUs), can suffer from high levels of stress, resulting in emotional exhaustion, diminished empathy for patients, and decreased productivity.


Tish Conwell

Latest:

Psychiatric Conditions Affecting Physicians With Disruptive Behavior

This study highlights the need to consider a holistic approach when discussing the problem of disruptive behavior in health care settings.


Tobias Wasser, MD

Latest:

Impacting Policies, Practices, and Other Physicians

Do you need to build leadership skills? Check out this 2024 APA Annual Meeting session from the American Association for Psychiatric Administration and Leadership!


Toby Measham, MD

Latest:

Taking Culture Into Account When Assessing a Young Patient

This list serves as a guide when treating persons of diverse cultures and backgrounds.


Todd A. Smitherman, PhD

Latest:

10 Salient Points About Migraine and Psychiatric Comorbidity

Where do migraines and psychiatric disorders intersect? Learn more.


Todd J. Farchione, PhD

Latest:

Development of a Transdiagnostic Unified Psychosocial Treatment for Emotional Disorders

Research emerging from the field of emotion science suggests that individuals who have anxiety and mood disorders tend to experience negative affect more frequently and more intensely than do healthy individuals, and they tend to view these experiences as more aversive, representing a common diathesis across anxiety and mood disorders.1-5 Deficits in the ability to regulate emotional experiences, resulting from unsuccessful efforts to avoid or dampen the intensity of uncomfortable emotions, have also been found across the emotional disorders and are a key target for therapeutic change.


Todd N. Schirmer, PhD

Latest:

Mobile Apps for Mental Health

Here: a look at Mobilyze and CrossCheck--2 apps currently in development that are embedded within smartphones and designed to capture objective data on patients to provide timely treatment and relapse prevention.


Tom Wooldridge, PsyD

Latest:

Macho, Bravado, and Eating Disorders in Men: Special Issues in Diagnosis and Treatment

Eating disorders are still thought of as a “female problem.” But 25% of those with anorexia and 36% of those with bulimia are males.


Tony Cohn, MD

Latest:

Metabolic Monitoring for Patients on Antipsychotic Medications

In this CME article, the focus is on the significance of metabolic changes that develop during antipsychotic treatment, as well as on strategies to incorporate metabolic monitoring into clinical practice.


Tony P. George, MD, FRCPC

Latest:

Using Brain Science to Develop Better, Safer, More Effective Treatments

Deep brain stimulation for substance use disorders when everything else fails, the history of the ACNP, and more.


Travis K. Svensson, MD

Latest:

Point

Prior to training in psychiatry, my practice was in a rural primary care setting where I routinely collaborated closely with physician assistants and nurse practitioners. I see prescriptive privileges of one form or another for psychologists to be an inevitability. I watched a similar struggle for nurse practitioner prescriptive privileges in Oklahoma during my stint in primary care. My recommendations to physicians in California would be to endorse prescriptive privileges for other mental health professionals in the format of the "physician extender" model similar to the traditional physician assistant.


Tsung-Ping Su, PhD

Latest:

Understanding the Role of Sigma-1 Receptors in Psychotic Depression

Selective serotonin reuptake inhibitors have been shown effective in the treatment of depression with psychosis. This efficacy appears to correlate with the SSRIs’ level of affinity at the sigma-1 receptors in the brain. What role does the sigma-1 receptor play in psychotic depression? Based on this role, are there implications for other treatments?


TsungWai Aw, MD

Latest:

Psychogenic Non-Epileptic Seizures: Clinical Issues for Psychiatrists

The authors shed light on a disorder that is difficult to diagnose and manage, and offer insights on how to develop an appropriate treatment plan.


Ulrike Feske, PhD

Latest:

Implications for Treatment and Prognosis of Borderline and Substance Use Disorders

Borderline personality disorder (BPD) and substance use disorder (SUD) often co-occur. Comorbid BPD and SUD is related to a variety of severe adverse outcomes.


Ute Lewitzka, MD

Latest:

What Role Does (Should) Lithium Play in Suicide Treatment/Prevention?

An interesting pharmacological approach in terms of anti-suicidal strategies is the use of lithium for treatment of patients with affective disorders. Details here.


Uzoezi Ozomaro, MD, PhD

Latest:

Personalized Medicine and Psychiatry: Dream or Reality?

This article explores the current state of knowledge regarding personalized medicine in psychiatry and discusses how the tools might be used to help psychiatrists understand the components of their patients’ unique endophenotypic profiles.


Valdesha L. Ball, MD

Latest:

Racial Encounters in Medicine

As an intern fulfilling my internal medicine outpatient rotation requirement, I worked in an urgent care walk-in clinic. One afternoon, I entered the waiting room to meet my last patient of the day. He was a 65-year-old white man who was receiving a workup for renal carcinoma.


Valentina Jalynytchev, MD

Latest:

Role of Acupuncture in the Treatment of Depression

Acupuncture is associated with an increase in the level of neurobiologically active substances, such as endorphins and enkephalins. There are also data indicating that acupuncture induces the release of norepinephrine, serotonin, and dopamine.


Vandana Aspen, PhD

Latest:

Patient Resistance in Eating Disorders

Why do patients with eating disorders resist treatment? How can the clinician address resistance?


Vanessa Torres-Llenza, MD

Latest:

7 Medical Illnesses That May Present as Anxiety

Beyond psychosocial implications of anxiety disorders, an array of physiological effects may ensue.


Vani Rao, MD

Latest:

Pharmacological Management of the Psychiatric Aspects of Traumatic Brain Injury

Traumatic brain injury (TBI) is a public health epidemic. Psychiatric symptoms after TBI are not just common, but also troublesome.


Vernon A. Rosario, MD, PhD

Latest:

Erotic and Psychological Identities

When people turn to mental health professionals about sexual problems-cyber or otherwise-how comfortable and informed are we?


Veronica Hackethal, MD

Latest:

Neurological and Psychiatric Effects of Dermatology Drugs

A review of systemic medications for dermatologic diseases describes a wide range of adverse events, which range from mild and reversible to permanent and potentially fatal.


Vicky Stergiopoulos, MD

Latest:

Shelter-Based Collaborative Mental Health Care for the Homeless

Homelessness rates in both Canada and the United States have increased dramatically over the past 10 years. Among the homeless, there is a high prevalence of mental illness and substance use disorders.


Victor G. Carrion, MD

Latest:

Treatment of Traumatic Stress Disorder in Children and Adolescents

The role of prevention of trauma and prevention of functional impairment after trauma is paramount, because this may disrupt the accumulated physiological and psychological effect of stressors in the individual.


Victor Schwartz, MD

Latest:

Stress Reactions to COVID-19

This video examines the differences between typical, non-pathological reactions to the stress induced by the COVID-19 pandemic and psychopathology (or mental illness).


Victoria Hendrick, MD

Latest:

Hormones for Perimenopausal and Postmenopausal Depression

Mood and well-being are believed to be regulated by mechanisms of estrogen and progesterone. How effective are they in the treatment of major and minor depression?


Vijaya Lakshmi Appareddy, MD

Latest:

Issues in Treating Patients With Intellectual Disabilities

Psychiatric disorders in persons with intellectual disabilities are typically more severe and more difficult to diagnose than in the general population. Clearly, those who diagnose ID and treat patients with this condition face a number of challenges.


Vikram Shah, MD, MBA

Latest:

Seeing the Forest Through the Fees: Earning Your Green Using the New, Confusing CPT Codes

E&M codes are more complicated to learn, but psychiatrists can now deservedly get paid more for treating their more complicated patients or for engaging in time-consuming activities. Here: a focus on codes 99212 to 99215.

© 2024 MJH Life Sciences

All rights reserved.